BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 5368199)

  • 1. [Proliferative kinetics of human genital carcinoma following the action of cytostatics and hormones in in vivo tests].
    Heckmann U; Hamann A; Inamoto E
    Zentralbl Gynakol; 1969 Aug; 91(33):1057-61. PubMed ID: 5368199
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy in gynecologic cancer.
    Savage EW; Maidman JE
    Obstet Gynecol Annu; 1976; 5():339-430. PubMed ID: 185550
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progestational hormones in the treatment of gynecologic cancers].
    Soutoul JH; Lagabrielle V
    Presse Med (1893); 1969 Feb; 77(7):247-9. PubMed ID: 5795418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of gynceologic diseases with ovarian hormones].
    Friedrich F
    Wien Med Wochenschr; 1973 Jan; 123(1):11-4. PubMed ID: 4683448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytostatic treatment of genital carcinoma].
    Limburg H
    Zentralbl Gynakol; 1969 Sep; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W; Preibsche W; Marzotko F
    Arch Geschwulstforsch; 1973; 41(3):241-7. PubMed ID: 4732846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antineoplastic chemotherapy in dermatology. Clinical experimental and anatomico pathologic study on the activities of some antimitotics. Findings in the general and local therapy].
    Scotti G
    Omnia Med Ther; 1970; 48(3):209-348. PubMed ID: 4108231
    [No Abstract]   [Full Text] [Related]  

  • 9. Gynecologic oncology.
    Lewis GC
    Semin Drug Treat; 1973; 3(1):101-16. PubMed ID: 4733201
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of genital cancers with polychemotherapy. Contribution to their study].
    Sonkin R; Coudeyras M; Blondon J
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(1):61-9. PubMed ID: 5038021
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in gynecologic cancer.
    Smith JP
    Clin Obstet Gynecol; 1975 Dec; 18(4):109-24. PubMed ID: 174855
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG; Ullery JC; Pace W
    Ohio State Med J; 1971 Aug; 67(8):721-5. PubMed ID: 4105456
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 14. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD
    Proc Natl Cancer Conf; 1970; 6():365-85. PubMed ID: 5458106
    [No Abstract]   [Full Text] [Related]  

  • 15. [After care of female genital and breast cancer].
    Klose G
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(4):278-85. PubMed ID: 4320658
    [No Abstract]   [Full Text] [Related]  

  • 16. [New viewpoints on using anabolic steroids in gynecologic radiotherapy, including animal experimental studies in healthy and tumor-vaccinated mice and rats].
    Picha E
    Strahlentherapie; 1969 Sep; 138(3):300-22. PubMed ID: 5349536
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro testing and clinical experience with 5-fluorouracil in gynaecologic cancer (author's transl)].
    Marzotko F; Krafft W; Preibsch W; Schröder M
    Arch Geschwulstforsch; 1976; 46(2):140-5. PubMed ID: 962505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance formation in the cytostatic treatment of carcinomas].
    Heckmann U; Tranckjer AS; Harms J
    Zentralbl Gynakol; 1969 Sep; 91(37):1204-10. PubMed ID: 5368211
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ozone-oxygen injection in gynecological radiotherapy].
    Hernuss P; Müller-Tyl E; Dimopoulos J
    Strahlentherapie; 1974 Sep; 148(3):242-5. PubMed ID: 4446040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.